Marissa Reitsma, lead author of two of three new global studies on tobacco published in The Lancet, discusses insights and key takeaways from her research.
Parkes Kendrick, lead author of a new global study on chewing tobacco, discusses her research and the devastating health impacts of this harmful habit.
Maria Carmona, Director of International Research for the Campaign For Tobacco-Free Kids, discusses the importance of protecting women, adolescents, and young adults from tobacco marketing.
Luisa Flor, Senior Fellow at IHME, discusses risk factors of secondhand smoke.
Chukwuma Okereke, Data Extraction Analyst at IHME, discusses survey methods and findings from three new global studies published in The Lancet on tobacco.
The study models two indicators: prevalence of current smoking tobacco use among young adults aged 15-24 years, and the age at which current smokers aged 20-54 years in 2019 began smoking regularly.
We estimated prevalence of chewing tobacco use with a modelling strategy that used information on multiple types of smokeless tobacco products.
We estimated the prevalence of smoking tobacco use and attributable disease burden for 204 countries and territories, by age and sex, from 1990 to 2019.
The most comprehensive data on global trends in smoking highlight its enormous global health toll. The number of smokers worldwide has increased to 1.1 billion in 2019, with tobacco smoking causing 7.7 million deaths worldwide.
14-25 years is a critical window for intervention.
Global prevalence of young smokers has decreased, but in some regions the absolute number is increasing.
Since 1990, the prevalence of smoking has decreased steadily around the globe. However, as populations have grown, the total number of smokers around the world has increased.
This study aims to estimate health care systems' value in treating major illnesses for each US state and identify system characteristics associated with value.
In this study we examined delays during the search for care process and associations with mother, child, or health services characteristics, and with symptoms report prior to death. The cross-sectional study comprises household interviews with 252 caregivers of children under-5 who died in the state of Yucatán, Mexico, during 2015-2016. Results indicate that children faced important delays in accessing care, particularly regarding the identification of symptoms and the initiation of the search for care process. These findings suggest that providing resources to enable caregivers to access health services in a timely manner may reduce delays in seeking care.
Per this study, uncorrectable visual acuity loss and blindness are even larger drivers of health burden in the US than was previously known.
We analyzed California’s racial/ethnic disparities in COVID-19 exposure risks, testing rates, test positivity, and case rates through October 2020.
This analysis introduces a publicly available evaluation framework for assessing the predictive validity of COVID-19 mortality forecasts.
An epidemiological analysis of the prevalence of high BMI, stroke, IHD, and T2DM was conducted for 16 Southern Africa Development Community (SADC) using Global Burden of Diseases, Injuries, and Risk Factors (GBD) Study data.
Professor David Pigott presents on COVID-19 modeling as part of the Health Metrics Sciences lecture series.
New analysis from IHME highlights the true toll of the pandemic.
We study the factors associated with observed trends in the in-hospital mortality rates in the United States during the first 9 months of the COVID-19 pandemic.
Study suggests hospital mortality rates dropped rapidly in the United States after May 2020 but have not declined further.
An indicator for malaria suspected cases with malaria test (MSCT) is proposed to measure the rate of testing on persons presenting to health facilities who satisfy the definition of a suspected malaria case.
Professor Heidi Larson, Director of the Vaccine Confidence Project, encourages everyone to get vaccinated and help bring an end to the pandemic.
Professor Heidi Larson, Director of the Vaccine Confidence Project, explains how factors like misinformation, trust in the government, and religious beliefs can impact willingness to take vaccines.